Loading patent…
AssigneeUniversity of Virginia
InventorsMarie Hanigan, Timothy MacDonald
Estimating the term…
An antibody is provided which binds to active GGT, and can identify tissues which express GGT on their surface. Many solid tumors express GGT on their surface. Individuals identified with such tumors may be treated with inactivated prodrugs of chemotherapeutic agents at local dosage levels substantially above the maximum dosage levels currently permitted due to side effect limitations. The prodrugs are comprised of chemotherapeutic agents rendered inactive by the attachment of a gamma-glutamyl group thereto. The gamma-glutamyl group is cleaved by GGT on the surface of solid tumor cells expressing GGT, and thus active only locally against the tumor. Side effects are suppressed. The antibody is used to identify solid tumors that are candidates for this treatment, as well as to identify tissues which express GGT and which must therefore be the basis of selection criteria of various available chemotherapeutic agents.
A method of assaying a tissue culture sample for the presence of gamma-glutamyl transpeptidase (GGT) expression, comprising combining an isolated antibody specific for a peptide having SEQ. ID. NO:1 with said tissue sample under conditions which permit antibody binding, and inspecting said sample to determine whether binding of said antibody has occurred, wherein any such binding is indicative of the presence of GGT expressing tissue.
An isolated antibody which binds specifically to a polypeptide having SEQ. ID. NO:1.
An isolated antibody produced by immunization of a mammal with a composition comprised of a polypeptide having SEQ. ID. NO:1, said polypeptide being conjugated to keyhole limpet hemocyanin, wherein said conjugate, when injected into a mammal, induces an immune response in the mammal to produce antibodies which bind specifically to said polypeptide.
An isolated antibody which binds specifically to the peptide backbone of the active form of gamma-glutamyl transpeptidase (GGT), wherein said antibody does not specifically bind to the inactive form of GGT encoded by alternately spliced human MRNA of liver, kidney, brain, intestine, stomach, placenta and mammary gland tissues.
Dependencies are inferred from the claim text.